A T/O offer of 75c is laughable.
Considering what we're going to have to put on the table in the first place in order to attain that offer.
Once the data (which takes a long time to acquire) is available, then mgmt will know what we're worth. So will BP.
7+ b shares is irrelevant.
Look at that post I provided last week regarding Novo Nordisk's $200b increase in 12 months based on the popularity of their weight loss drug Ozempic.
You simply don't understand the potential of the products we're working on. Especially CF33. 50% of the global population is at risk of cancer. That's more than Oprah's desire to lose a couple of kg
IMU is all or nothing. IMO there is no other option.
A T/O offer of 75c is laughable. Considering what we're...
-
- There are more pages in this discussion • 4,769 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
